Table 1

Demographic and clinical details, for Indigenous and non-Indigenous patients with cancer of the head and neck in Queensland Australia, 1998- 2004

Indigenous Status

P value

Indigenous

N = 67

N %

Non-Indigenous

N = 62

N %

Cancer site (ICD code)

Floor of Mouth (C04)

5 (8)

7 (11)

Gum (C03)

1 (2)

3 (5)

Hypopharynx (C13)

1 (2)

2 (3)

Lip, oral cavity, pharynx - ill defined (C14)

9 (13)

6 (10)

Nasopharynx (C11)

3 (5)

2(3)

Oropharynx (C10)

5 (8)

2 (3)

0.26

Palate (C05)

8 (12)

2 (3)

Parotid (C07)

3 (5)

7 (11)

Pyriform Sinus (C12)

7 (10)

7 (11)

Tongue (C01- C02)

15 (22)

20 (32)

Tonsil ( C09)

5 (8)

4 (7)

Unspecified Salivary glands (C08)

1 (2)

0

Unspecified mouth (C06)

4 (6)

0

Age

18- 39

2 (3)

4 (7)

40-59

40 (60)

39 (63)

0.52

60+

25 (37)

19 (30)

Sex

Male

47 (70)

43 (70)

0.92

Female

20 (30)

19 (30)

Area of remoteness (ARIA)

Highly accessible

11 (17)

7 (11)

Accessible

9 (14)

10 (16)

0.28

Moderately accessible

25 (37)

33 (53)

Remote

9 (13)

6 (10)

Very remote

13 (19)

6 (10)

Socioeconomic status (SEIFA )

1 Most disadvantaged

26 (39)

13 (21)

2 Low to Intermediate advantage

13 (19)

20 (32)

3 Intermediate advantage

13 (19)

13 (21)

0.19

4 Advantaged

11 (16)

12 (19)

5 Most advantaged

4 (6)

2 (3)

9 Not known

0

2 (3)

Stage at diagnosis (SEER score)

Localised cancer

23 (34)

15 (24)

Regional Spread

38 (57)

40 (65)

0.41

Distant metastasis

5 (7)

7 (11)

Not sure

1 (2)

0

Charlson Comorbidity Index (Scores grouped)

0

42 (63)

42 (68)

1

16 (24)

8 (13)

0.30

2- 5

9 (13)

11 (18)

5+

0

1 (2)

Specific comorbidities

Diabetes

No

59 (88)

60 (97)

0.09

Yes

8 (12)

2 (3)

Hypertension

No

55 (82)

47 (76)

0.39

Yes

12 (18)

15 (24)

Circulatory disease*

No

61 (91)

51 (82)

0.19

Yes

6 (9)

11 (18)

*Cardiovascular or cerebrovascular disease

Moore et al. BMC Cancer 2011 11:460   doi:10.1186/1471-2407-11-460